Jayamas Medica Industri Tbk. vs Abadi Lestari Indonesia Tbk. — how do they compare? Jayamas Medica Industri Tbk. trades at Rp208 (market cap 5.47T, 47.06M 24h volume), while Abadi Lestari Indonesia Tbk. trades at Rp4,000 (market cap 11.66T, 1.52M 24h volume). The key difference: Abadi Lestari Indonesia Tbk. is far larger — about 2.1× Jayamas Medica Industri Tbk.'s market cap, and Jayamas Medica Industri Tbk. is more actively traded (47.06M versus 1.52M). Which is the better fit depends on your goals.
| OMED | RLCO | |
|---|---|---|
Market Cap | 5.47T | 11.66T |
Volume | 47.06M | 1.52M |
Lot | 470.58K | 15.22K |
Turnover | 9.56B | 5.89B |
Average Price | 203.11 | 3,870.8 |
Value | 9.56B | 5.89B |
Indicative Equilibrium Price | 208 | 4,000 |
Indicative Equilibrium Volume | 5.06K | 269 |
Trailing returns across standard periods
Latest headlines on both assets
PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Read more on OMED →PT Abadi Lestari Indonesia (the Entity) was established based on Notarial Deed No. 166 of Siti Nurul Hidajah, S.H., M.Kn., Notary in Bojonegoro, dated August 11, 2014. The Entity started its commercial operations in 2014. PT Abadi Lestari Indonesia is the parent entity, whereas Edwin Pranata is the ultimate beneficial owner of the group.
Read more on RLCO →